The Toronto group has recently published their long-term (20-year) results with the Ross procedure (Ross) vs bioprosthetic aortic valve replacement (AVR) in a propensity-score matched analysis.1 The authors concluded that Ross was associated with significantly better long-term survival and freedom from adverse valve-related events and should therefore be considered as the primary option for young and middle-age adults undergoing AVR. [...]
Jahanyar, J., Mastrobuoni, S., Said, S. M., El Khoury, G., & de Kerchove, L. (2022). Lack of Clinical Equipoise Renders Randomized-Trial Execution of Ross vs Prosthetic Valves an Impossible Task. Journal of the american college of cardiology : JACC, 80(1), e7. https://doi.org/10.1016/j.jacc.2022.04.043 (Original work published 2022)